Logo 1 Logo 2

Clinical Trial Details

Trial ID: L2090
Source ID: NCT01931982
Associated Drug: Victoza
Title: Effect of Glucagon-like Peptide 1 (GLP-1) on Microvascular Myocardial Function in Patients With Type 2 Diabetes.
Acronym: EGOFIP
Status: COMPLETED
Study Results: NO
Results:
Conditions: Type 2 Diabetes|Microvascular Dysfunction
Interventions: DRUG: Victoza
Outcome Measures: Primary: Change in coronary flow reserve (CFR), CFR can be reliably assessed non-invasively by trans-thoracic Doppler flow echocardiography of the left anterior descending artery with a success rate of over 90% even in an obese population with a relative poor acoustic window. CFR is the ratio of flow during stress to during rest., CFR is measured at baseline and after 10 weeks of intervention | Secondary: Change in Endothelial function:, Measurement of Peripheral Arterial Tone, with the use of the commercially available machine (Endo-PAT2000®) assesses the control of digital vascular tone by the sympathetic nervous system and nitric oxide (NO)., Endothelial function is measured at baseline and after 10 weeks of intervention | Other: Changes in HbA1c, Measurements at baseline and after 10 weeks of intervention|Change in fasting C-peptide, C-peptide is measured at baseline and after 10 weeks of intervention|Change in fasting insulin, Fasting insulin is measured at baseline and after 10 weeks of intervention|Change in fasting glucose, Fasting glucose is measured at baseline and after 10 weeks of intervention|Change in weight, Weight is measured at baseline and after 10 weeks of intervention|Change in waist circumference, Waist circumference is measured at baseline and after 10 weeks of intervention
Sponsor/Collaborators: Sponsor: Bispebjerg Hospital
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases: PHASE4
Enrollment: 20
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: SINGLE (INVESTIGATOR)|Primary Purpose: TREATMENT
Start Date: 2013-05
Completion Date: 2014-04
Results First Posted:
Last Update Posted: 2014-06-25
Locations: Bispebjerg Hospital, Copenhagen, Capital region, 2400, Denmark
URL: https://clinicaltrials.gov/show/NCT01931982